While its primary focus was device regulatory scope (FDA found the Exer Scan was marketed beyond the limits of its 510(k) exemption), the letter also enumerated major quality system deficiencies lack of design control procedures, no CAPA system, no complaint-handling SOPs, no auditing processes, etc
Fair enough, but thats only half of the story, and heres the other half: There are around nine research studies that Medifast has been a part of, the follow up time was never longer than 12 months, except for in one case, when follow up was done after 86 weeks
Sign up for LIFTED GLP-1 Blueprint today to get your discount code
OHSS, ovarian hyperstimulation syndrome
B12 injections are typically administered directly into the muscle, known as intramuscular injection
5i), demonstrating that these oxidized TAG species are generated in an ESA and ACSL1-dependent manner